Why is FATE Down Today?
About Fate Therapeutics, Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, in...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
NORMAL - This move is backed by significant volume and appears sustainable.
📍 Sector Context
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector: -0.6%
Market Comparison
Quick Trade Ideas
Options strategies to consider for FATE's -7% move
No Options Available
FATE doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get FATE Alerts
We'll notify you when FATE's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
FATE has moved more than 3.0% down on 65 occasions in the past year.
Frequently Asked Questions
Why is FATE stock down today?
This stock is significantly underperforming its BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector peers, suggesting a stock-specific catalyst.
Is FATE stock a buy or sell right now?
Based on current analysis, FATE shows 65% confidence in today's move. Volume is moderate which supports the trend. View full buy/sell analysis →
What is the FATE stock price target?
FATE is currently trading at $1.65. Based on today's momentum, the expected short-term range is $1.60 - $1.68. See long-term price prediction →
Will FATE stock continue falling?
Our analysis shows a 45% probability that FATE's move continues in the next 1-3 days. Key level to watch: $1.56 (support).
Is FATE stock oversold or overbought?
FATE's RSI (Relative Strength Index) is currently at 31.7. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for FATE stock?
FATE's 10-day momentum indicator is at -0.53. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is FATE outperforming or underperforming the market?
FATE (-7.06%) is currently significantly underperforming the market (-8.4% vs SPY). Today, the S&P 500 (SPY) is up 1.38%, and Nasdaq (QQQ) is up 2.49%.
What does MACD indicate for FATE?
FATE's MACD (-0.11) is currently below the signal line (-0.08), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 13.9) is weak.
Is FATE in an uptrend or downtrend?
Based on moving average analysis, FATE is in a bearish trend. The price ($1.65) is trading below both the 20-day SMA ($1.98) and 50-day SMA ($2.2). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis